ClinicalTrialsFinder
RecruitingNCT05775757

SMC Radiation Oncology Breast Cancer Cohort Study

Registry for Analysis of Impact of Radiation Dose to Skin on Cosmetic Outcome and Patient-reported Outcomes in Patients With Breast Cancer Treated With Radiation Therapy

Sponsor

Samsung Medical Center

Enrollment

500 participants

Start Date

Jan 1, 2021

Study Type

OBSERVATIONAL

Conditions

Radiotherapy Side Effect

Summary

The goal of this observational study is to learn about toxicities and cosmetic outcomes in breast cancer patients treated with hypofractionated radiotherapy. The main question it aims to answer are: * Changes in breast skin * Factors related to breast skin changes * Patient-reported outcomes * Cosmetic outcomes Participants will be assessed by multi-dimensional methods before and after radiotherapy: * Photographs * Fibrometer * Questionnaires (BREAST-Q) * CTCAE version 4.03 evaluated by treating physicians

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This is a long-term observational study following breast cancer patients who have had curative surgery and received radiation therapy. Researchers are collecting clinical data to better understand outcomes, side effects, and treatment patterns over time. **You may be eligible if...** - You have been diagnosed with breast cancer and treated with curative surgery - You have received radiation therapy as part of your breast cancer treatment **You may NOT be eligible if...** - You have a history of prior radiation therapy to the chest area Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONHypofractionated radiation therapy

Both 3-week and 1-week hypofractioanted radiation therapy are allowed. (simultaneous or sequential tumor bed boost is allowed.) A 3-week regimen includes 42.4 Gy in 16 fractions. A 1-week regimen includes 26 Gy in 5 fractions or 28.5 Gy in 3 fractions, 30 Gy in 5 fractions.

Locations(1)

Samsung Medical Center

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05775757

Related Trials

ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer

NCT0488992460 locations

Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years

NCT066187033 locations

Curatively Intended Thoracic Reirradiation

NCT069500731 location

Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume

NCT0671944023 locations

RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3

NCT062979023 locations